Adm1n: Created page with "'''MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122)''' is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been report..."

2015-02-15T12:56:47Z

Created page with "'''MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122)''' is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been report..."

New page

'''MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122)''' is a drug that presumably acts as a potent agonist for the [[cannabinoid receptors]]. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in [[Synthetic Cannabis]] smoking blends.Like [[RCS-4]] and [[AB-001]], MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known [[cannabinoid]] compounds [[JWH-122]] and [[AM-2201]], both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries. MAM-2201 has been banned by being added to the temporary class drug schedule in New Zealand, effective from 13 July 2012.

MAM-2201 - Revision history

Adm1n: Created page with "'''MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122)''' is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been report..."